Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma

Xiangsu Xu; Qingshun Meng

doi:10.36721/pjps/31/4(Special)/04.07.2018/6360/1751-1755

original articles

Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma

Xiangsu Xu, Qingshun Meng

Vol. 31

Issue 4

Pages 1751-1755

Online Date: 31 Jul 2018

Published: 31 Jul 2018

DOI: 10.36721/pjps/31/4(Special)/04.07.2018/6360/1751-1755

Authors Abstract Related

Authors & Affiliations

Xiangsu Xu

Qingshun Meng

Abstract

Sorafenib is a new multi-target oral drug that inhibits many kinds of protein kinase small molecules to treat tumors

Keywords

Sorafenib

transcatheter arterial chemoembolization

drug effect

tumor cell

Metrics

PlumX Metrics

original articles

Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma

Xiangsu Xu, Qingshun Meng

Vol. 31

Issue 4

Pages 1751-1755

Online Date: 31 Jul 2018

Published: 31 Jul 2018

DOI: 10.36721/pjps/31/4(Special)/04.07.2018/6360/1751-1755

Authors Abstract Related

Authors & Affiliations

Xiangsu Xu

Qingshun Meng

Abstract

Sorafenib is a new multi-target oral drug that inhibits many kinds of protein kinase small molecules to treat tumors

Keywords

Sorafenib

transcatheter arterial chemoembolization

drug effect

tumor cell

Metrics

PlumX Metrics

Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Drug effect analysis of sorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma

Authors & Affiliations

Abstract

Keywords

Metrics